Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients

被引:50
作者
Hong, A. M. [1 ,2 ]
Millington, S. [3 ]
Ahern, V. [4 ]
McCowage, G. [5 ]
Boyle, R. [3 ]
Tattersall, M. [2 ,6 ]
Haydu, L. [2 ]
Stalley, P. D. [3 ]
机构
[1] Royal Prince Alfred Hosp, Dept Radiat Oncol, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Orthopaed Surg, Sydney, NSW, Australia
[4] Westmead Hosp, Dept Radiat Oncol, Sydney, NSW, Australia
[5] Childrens Hosp Westmead, Dept Paediat Oncol, Sydney, NSW, Australia
[6] Royal Prince Alfred Hosp, Dept Med Oncol, Sydney, NSW, Australia
关键词
chondrosarcoma; Ewing's sarcoma; extracorporeal; osteosarcoma; radiation; sarcoma; ITALIAN-SARCOMA-GROUP; EWINGS-SARCOMA; NEOADJUVANT CHEMOTHERAPY; FOLLOW-UP; OSTEOSARCOMA; IFOSFAMIDE; ALLOGRAFTS; RECONSTRUCTION; CHONDROSARCOMA; METHOTREXATE;
D O I
10.1093/annonc/mdt252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
En bloc resection, extracorporeal irradiation (ECI) and reimplantation have been used selectively at our centers as part of limb preservation surgery of malignant bone tumors since 1996. We report the long-term oncological outcomes. One hundred one patients were treated with ECI at two Australian centers between 1996 and 2011. A single dose of 50 Gy was delivered to the resected bone segments. The irradiated bones were reimplanted immediately as a biological graft. Patients were treated with chemotherapy as per standard protocol. The three main histological diagnoses were Ewing's sarcoma (35), osteosarcoma (37) and chondrosarcoma (20). There were nine patients with a range of different histologies. There was one local recurrence (2.86%) in Ewing's sarcoma and the 5-year cumulative overall survival was 81.9%. There was no local recurrence in osteosarcoma and five distant recurrences. The 5-year cumulative overall survival was 85.7%. The local recurrence rate was 20% (4 of 20) in chondrosarcoma, and the 5-year cumulative overall survival was 80.8%. Limb preservation was achieved in 97 patients. For the 64 patients with disease in the pelvis or lower limb, 53 (82.3%) could walk without aids at the time of last follow-up. This large series of ECI shows an excellent long-term local control. It is a good alternative reconstruction method in selected patients. The overall survival is comparable to other published series.
引用
收藏
页码:2676 / 2680
页数:5
相关论文
共 20 条
  • [1] MASSIVE ALLOGRAFTS IN THE TREATMENT OF OSTEOSARCOMA AND EWING SARCOMA IN CHILDREN AND ADOLESCENTS
    ALMAN, BA
    DEBARI, A
    KRAJBICH, JI
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1995, 77A (01) : 54 - 64
  • [2] Osteosarcoma, chondrosarcoma, and Ewing's sarcoma
    Damron, Timothy A.
    Ward, William G.
    Stewart, Andrew
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2007, (459) : 40 - 47
  • [3] En-bloc resection, extracorporeal irradiation, and re-implantation in limb salvage for bony malignancies
    Davidson, AW
    Hong, A
    McCarthy, SW
    Stalley, PD
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2005, 87B (06): : 851 - 857
  • [4] Allograft-prosthetic composite in the proximal tibia after bone tumor resection
    Donati, Davide
    Colangeli, Marco
    Colangeli, Simone
    Di Bella, Claudia
    Mercuri, Mario
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2008, 466 (02) : 459 - 465
  • [5] Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups
    Ferrari, S
    Smeland, S
    Mercuri, M
    Bertoni, F
    Longhi, A
    Ruggieri, P
    Alvegard, TA
    Picci, P
    Capanna, R
    Bernini, G
    Müller, C
    Tienghi, A
    Wiebe, T
    Comandone, A
    Böhling, T
    Del Prever, AB
    Brosjö, O
    Bacci, G
    Sæter, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8845 - 8852
  • [6] Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1
    Ferrari, Stefano
    Ruggieri, Pietro
    Cefalo, Graziella
    Tamburini, Angela
    Capanna, Rodolfo
    Fagioli, Franca
    Comandone, Alessandro
    Bertulli, Rossella
    Bisogno, Gianni
    Palmerini, Emanuela
    Alberghini, Marco
    Parafioriti, Antonina
    Linari, Alessandra
    Picci, Piero
    Bacci, Gaetano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) : 2112 - 2118
  • [7] Risk factors for survival and local control in chondrosarcoma of bone
    Fiorenza, F
    Abudu, A
    Grimer, RJ
    Carter, SR
    Tillman, RM
    Ayoub, K
    Mangham, DC
    Davies, AM
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B : 93 - 99
  • [8] Fox EJ, 2002, CLIN ORTHOP RELAT R, P106
  • [9] Factors affecting outcome of massive intercalary bone allografts in the treatment of tumours of the femur
    Frisoni, T.
    Cevolani, L.
    Giorgini, A.
    Dozza, B.
    Donati, D. M.
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2012, 94B (06): : 836 - 841
  • [10] The relative costs of proton and X-ray radiation therapy
    Goitein, M
    Jermann, M
    [J]. CLINICAL ONCOLOGY, 2003, 15 (01) : S37 - S50